Engineering Drawings Reveal Wider Column Deficiencies at Former Pfizer Headquarters
Engineering drawings obtained by The New York Times show that eight additional steel columns at 235 East 42nd Street lacked sufficient reinforcement, according to reporting published August 28, 2026. The findings expand the known scope of structural problems well beyond the two columns that buckled on July 7, an event that forced evacuations and triggered an emergency stabilization effort at the Midtown Manhattan high-rise.
The building — the former Pfizer headquarters — was in the middle of a conversion into 1,600 apartments when two of its support columns buckled on July 7. Responding authorities found two mangled columns on the 21st floor along with multiple cracks, according to the Associated Press. The failures set off immediate evacuations and left the building at risk of collapse before crews completed stabilization measures by July 8.
The Times's reporting on the engineering drawings adds a new layer to what had been understood as a localized failure. Think of it like a leaky roof: the two buckled columns were the visible drip, but the drawings reveal that the underlying condition — insufficient steel reinforcement — extends across more of the structural frame, not just the spots where things gave way.
This distinction matters for several reasons. First, the scope of repairs grows considerably when deficient columns extend beyond the two that already failed. Second, engineering drawings serve as a kind of blueprint record of what was actually designed or built, which is essential for determining whether the problem originated in the original design, in how the steel was fabricated, or in how it was assembled on site. Third, for a building that has already been stabilized and is still on a conversion path, the discovery of additional under-reinforced columns raises the question of whether the fixes already applied address all of the structural vulnerabilities — or only the ones that became visible.
The timeline itself is worth tracking. The buckling occurred on July 7. Authorities confirmed stabilization by July 8. The Associated Press identified the building as the former Pfizer headquarters on July 10. Nearly seven weeks passed before the engineering drawings surfaced through The Times's reporting on August 28, revealing that the column deficiency was more extensive than the initial two-column failure suggested.
The broader context here is about what happens when older commercial buildings are converted to residential use at scale. The former Pfizer headquarters was being transformed into 1,600 apartments, a project that involves substantial structural modification. In any such conversion, column reinforcement — the steel embedded in or wrapped around a column to help it bear weight — is a fundamental part of the load path, the route that gravity travels from the top of a building down to its foundation. The discovery that multiple columns lacked adequate reinforcement suggests that whatever structural assessment took place before construction did not catch these deficiencies before they became critical.
The engineering drawings now in the public record provide a detailed picture of the steel framing's condition — far more than the physical evidence of buckled columns alone could convey. Whether the reinforcement deficiencies documented in these drawings matched the original construction plans or represented deviations from what was intended is a question the available reporting does not resolve. What the drawings do establish is that the structural condition at 235 East 42nd Street was more deficient, across more columns, than the July buckling incident alone indicated.
